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Abstract 
The structure and function of muscles are vital to human health and mobility. Muscle 
fibers contain contractile proteins organized into units called sarcomeres that are necessary for 
muscle function. Mutations in proteins of the sarcomere, such as in the Myosin regulatory light 
chains, can lead to degenerative diseases in humans, such as nemaline and cardiac 
myopathies. These Myosin regulatory light chain proteins regulate Myosin heavy chain protein 
to alter the kinetics of muscle contraction. I hypothesize that mylpfa is necessary not only for 
Myosin heavy chain regulation, but also vital for sarcomere formation in fast muscle. To test 
this, we generated knockouts in four zebrafish Myosin light chain genes, mylpfa, mylpfb, myl1a, 
and myl1b. The mylpfa-/- mutants have severe defects in all fast muscle fibers, while sarcomeres 
in slow muscle fibers appear unaffected. Mutants for the second Mylpf in zebrafish, mylpfb-/-, 
appear normal, indicating that mylpfa is the more important of the two Mylpf homologs. 
Consistent with my hypothesis, mylpfa-/- mutant embryos have weakened muscles caused by 
severely disrupted sarcomere structure. Later, during larval stages, the weakened mylpfa-/- 
mutant muscle fibers degenerate, resulting in loss of fast muscle fibers. Thus, our findings 
reveal that in addition to their role in muscle contraction, Mylpf genes are vital to sarcomere 
formation and muscle fiber integrity in fast muscles. Further investigation into how mylpfa 
functions in sarcomere assembly and how sarcomere assembly influences fiber integrity may 







Figure 1. Rapid muscle development in zebrafish 
Illustrations of timeline of muscle development in zebrafish from 19.5 hours post fertilization 
(hpf) and 76 hpf. Green muscle represents trunk muscle, a population of both fast and slow 
muscle, Red indicates fin and hypaxial muscles, populations of pure fast muscle. Purple are 
facial muscles and are a mix of fast and slow muscle. 
 
Muscle fibers are long, multinucleated fibers that, span the length of myotomes in 
skeletal muscle. In zebrafish, trunk muscle forms very rapidly, allowing fish to move within 24 
hours post fertilization (hpf). After this initial rapid myogenesis, trunk muscle grows more slowly, 
and other muscle populations form by 52 to 76 hours post fertilization (hpf) (Figure 1) (Haines 
et al., 2004; Schilling and Kimmel, 1997). Long rod-like structures, known as myofibrils, 
compose muscle cells. Myofibrils contain the basic structural and contractile units, known as 
sarcomeres, throughout their length (Figure 2A) (Clark et al., 2002; Sanger et al., 2010). Thick 
filaments of Myosin proteins and thin filaments of Actin make up the sarcomere. The thick 
filaments ratchet along the thin filaments, pulling them in to shorten the sarcomere. When the 
sarcomeres throughout the myofibrils shorten, the myofibrils contract, thus contracting the 
muscles (Figure 2B) (Huxley, 2000). I hypothesize that the Myosin light chain mylpfa, a 
component of the thick filaments, is essential for sarcomere assembly, and thereby essential for 
normal muscle contraction and integrity. 
 
Figure 2. Sarcomeres are the basic contractile unit of muscles.  
(A) Illustration of a 3 days post fertilization (dpf) zebrafish embryo. First inset zooms in on the 
myotome of the trunk muscles. Confocal image shows fast muscles of the trunk (green) and 
myonuclei (blue). Second inset shows a confocal image of myofibers with Actin (red), Myosin 
heavy chains (green), and myonuclei (blue) labeled by antibodies.  (B) Illustration of sarcomere 
organization. Red thin filaments composed of Actin associate with green thick filaments of 
Myosins to make up the sarcomeres. (C) Illustration of Actin and Myosin interaction. The 
blue/green head regions of the Myosin heavy chains bind to the Actin (red) and ratchet them to 
shorten the sarcomere. Two classes of Myosin light chains, the Regulatory light chains (tan) and 
Essential light chains (purple), bind around the neck of the Myosin heavy chains and regulate 
the step size of Actin ratcheting. 
Several studies spanning many years and using a variety of model organisms, come to 
propose a three-step model for sarcomere development. In the first step of myofibrillogenesis, 
pre-myofibrils form along the length of myofibers by the interaction of Actin filaments and non-
muscle myosin. Next, muscle Myosin replaces the non-muscle Myosin and another sarcomeric 
protein, Titin, integrate themselves, forming nascent myofibrils. Third, other sarcomeric proteins 
that facilitate contraction and cross-link sarcomeric structures layer in, forming mature myofibrils 
(Du et al., 2003; Sanger et al., 2017). Recent work in Drosophila expanded on this model and 
highlights the importance of tension in the assembly of the sarcomeres. The authors of this 
study propose that Actin begins to align itself throughout the cell, but that it is not until cell 
elongation and the tension provided from muscle-tendon junctions that the Actin stretches out to 
span the length of the cell and associate with thick filaments (Lemke and Schnorrer, 2017). 
Before sarcomeres span the whole myofibers, micro-contractions may locally generate tension. 
These micro-contractions of sarcomeric structure throughout the length of the myofibril align the 
sarcomeres (Weitkunat et al., 2017). I hypothesize that the micro-contractions that align the 
sarcomeres require Myosin light chains, which are known to be involved in regulating muscle 
contraction (Takashima, 2009). Thus, in the absence of Myosin light chains, the myofibrils will 
lack sarcomeric organization and muscle integrity. 
I chose to focus on the Myosin light chains due to their known role in sarcomere 
contraction (Duggal et al., 2015). Myosin heavy chains require the Myosin light chains for 
normal movement along Actin filaments. Actin enzymatic activity is reduced by 50% and Actin 
velocity is reduced ten-fold when Myosin heavy chains are stripped of their light chains in vitro 
(Lowey et al., 1993a). Thus, null mutations in the Myosin light chain genes would be predicted 
to lead to a lack of the sarcomere contraction that reportedly organizes myofibril structure 
(Weitkunat et al., 2017). My research focuses on the fast skeletal muscles, which is a muscle 
type that contracts and fatigues quickly (Schiaffino and Reggiani, 2011; Talbot and Maves, 
2016). There are two categories of Myosin light chains within fast muscle: the regulatory light 
chain (RLC) and the essential light chain (ELC). Both types of light chains bind to the neck 
region of the skeletal muscle Myosin heavy chain; ELCs bind closest to the force-generating 
head region, while RLCs bind slightly further away from the head (Figure 2C). In humans, the 
fast muscle RLC is known as Mylpf and the ELC is Myl1. Myosin light chains in Drosophila tune 
heavy chain activity by changing the ratcheting step size and thereby governing how quickly and 
forcefully the muscle contracts (Burghardt et al., 2016). In particular, the long isoform of the ELC 
has an arm that binds to the actin filaments and regulate the ratcheting step size (Wang et al., 
2016). Based on the Drosophila work, one would expect similar phenotypes of muscle 
weakness in other species such as mice. Surprisingly, Myl1 enhancer knockout mice have 
severe mesodermal defects (Jiang et al., 2002) and mouse Mylpf-/- mutants lack muscle at birth 
(Wang et al., 2007). The severe phenotype of these mice is surprising since Myl1 and Mylpf 
were predicted to function in sarcomere contraction and not in muscle formation itself. Thus, the 
role of Myosin light chain gene function remains unclear during vertebrate development. I 
hypothesize that Myosin heavy chain association with Actin require Myosin light chains and that 
the force generated by Myosin ratcheting Actin is necessary for proper alignment of sarcomeric 
structures. Therefore, I predict that upon mutation of Myosin light chains, sarcomeric structure 
will not form, leading to muscle weakness, loss of muscle integrity, and ultimately to muscle 
fiber degeneration. 
To test this hypothesis, I focused on the Myosin light chain genes expressed in zebrafish 
fast muscles: mylpfa, mylpfb, myl1a, and myl1b. Zebrafish are effective model organisms to 
study the developmental role of Myosin light chains for several reasons: zebrafish have large 
clutch size, transparent embryos, rapid muscle growth, and have a fiber organization that lets us 
easily spot the fast muscle fibers. In humans, mixtures of fast and slow muscle fibers make up 
the muscles. In contrast, zebrafish trunks have spatially separated fast and slow fibers by one 
day post fertilization (dpf). Zebrafish have two copies of each fast-expressed Myosin light chain 
gene. The RLCs in zebrafish fast muscle are mylpfa and mylpfb and the ELCs are myl1a and 
myl1b. Null mutations for all four zebrafish Myosin light chain genes allow us to examine gene 
function early in the zebrafish development. Using live imaging of these mutant lines, I observed 
the muscle phenotype in the absence of each of the Myosin light chains. 
Together with other members of the Amacher lab, I isolated mutant lines for four of the 
Myosin light chains expressed in zebrafish fast muscles using CRISPR/Cas9 mutagenesis. 
Surprisingly, three of the myosin light chain mutants had no phenotype or only mild swimming 
defects but otherwise appeared like their wild-type siblings. In contrast, I found that mylpfa-/- 
mutants have significantly slower and weakened swimming. In mylpfa-/- mutants, Myosin heavy 
chains mostly fail to associate with Actin, instead forming globs of protein. Thus, my data 
suggest that mylpfa is the critical Myosin light chain for proper Myosin heavy chains and 
formation of sarcomeres throughout the myofibrils. Eventually, mylpfa-/- mutant muscle fibers 
degenerate, suggesting that without sarcomeric structure, muscle cells lack the integrity needed 
to maintain long, multinucleated fibers. mylpfa is thus necessary for sarcomere formation, and 
that without mylpfa, muscles are weaker and degenerate, perhaps through a mechanism of 







Fast muscle express Myosin light chain genes in similar patterns 
Gene homology and images on ZFin indicated that myl1a, myl1b, mylpfa, and mylpfb are 
expressed in fast muscles (Thisse et al., 2001; Thisse et al., 2004, Rauch et al., 2003). To 
ensure that these genes truly are fast muscle specific, I examined the mRNA expression 
patterns of the four fast muscle specific Myosin light chains using in situ hybridization. 
Fluorescent double in situs of each of the four Myosin light chains colabeled with a slow muscle 
marker show that each of the four Myosin genes have fast muscle-specific expression at 24 hpf 
(Figure 3A). Single chromogenic in situ hybridization shows that the four Myosin light chains 
are expressed in the fast skeletal muscles of zebrafish as early as 19.5 hpf (Figure 3B). The 
early trunk muscle expression of the four fast muscle-specific Myosin light chain genes differs 
from the expression of a slow muscle marker in the trunk by the absence of expression down 
the middle of the trunk alongside the notochord. Expression of all four of the fast Myosin light 
chain genes is maintained even after fast muscle has matured (52.5 hpf). The migratory 
muscles of the fin, face, and hypaxial muscles express the four Myosin light chains which form 
and migrate between the observed timepoints. Therefore, skeletal muscle expresses the four 
fast muscle-specific Myosin light chains in similar locations and at similar times.  
 
 
Figure 3. The four Myosin light chains exhibit similar fast muscle-specific RNA 
expression patterns.                 
(A) Confocal section of embryos labeled with probe to smyhc1 as a slow muscle marker in 
green with one of each of the four Myosin light chain genes marked in red. Scalebar: 100 
microns (B) Single RNA in situs of the four fast muscle specific Myosin light chain genes show 
fast muscle specific expression in the trunk beginning at 19.5 hpf that continues on through 52.5 
hpf. Additionally, the fast muscle-specific hypaxial and pectoral fin muscles express all four of 
the Myosin light chain genes at 52.5 hpf. 
 
Mutations in four Myosin light chain genes reveal Mylpfa as key for muscle organization 
 To test what the roles of the four Myosin light chains may be, I worked in collaboration 
with other members of the Amacher lab to mutate and identify lines carrying mutations in the 
four fast specific skeletal Myosin light chains using CRISPR/Cas9 mutagenesis. Our mutants 
cause an early frameshift mutation, likely truncating the proteins midway through the first EF 
Hand domain that binds the Myosin light chain to Myosin heavy chains. So, these mutations 
likely cause strong losses in gene function or are null. Examination of swimming behaviors in 
the four mutants revealed that mylpfa-/- mutants have severe defects. Thus, I have focused on 
the mylpfa-/- mutants for further characterization. The RLC have very similar amino acid 
sequences (Figure 4A), identical at 159 out of 170 sites, (94.1%). Thus, functional differences 
between the two genes is not likely caused by sequence differences. To test for differences in 
mutant phenotypes, I screened muscle organization in these mutants using the polarized light 
effect known as birefringence. mylpfb-/- homozygous mutants have normal birefringence.  In 
contrast, mylpfa homozygous mutants have reduced birefringence (Figure 4B). Only mylpfa-/- 
mutants exhibit a consistent reduction in birefringence, suggesting that mylpfa is the key Myosin 
light chain gene for sarcomere formation.  
Zebrafish express mylpfa at higher levels than the other Myosin light chains 
 These severe birefringence defects seen in the mylpfa-/- mutants are largely absent in 
mylpfb-/-. To explain why mylpfa may be the critical Myosin light chain gene, I examined RNA 
seq data from another Amacher lab member, Pooja Gangras, to see if there was a difference in 
the mylpfa RNA expression level compared to that of mylpfb. From this data, I found that mylpfa 
expression is higher than its duplicate, mylpfb (Figure 4C). Both Essential light chain mutants 
(myl1a and myl1b) appear to have normal birefringent character. I did detect moderate 
swimming defects in myl1a mutants. Based on similar analysis of RNA seq data from Pooja 
Gangras, myl1a and myl1b are expressed at similar levels to one another, though at much lower 
levels than mylpfa. I also confirmed this expression data using an online resource of RNA 
expression patterns in zebrafish (The European Bioinformatics Institute Expression Atlas). The 
online resource uses the alternative names for the Essential light chains: myl1a is referred to as 
myl1 and myl1b is referred to as mylz3. Perhaps we do not see severe defects in the ELC 
mutants because either ELC gene can suffice for sarcomere organization and muscle function. 
However, since myl1a and myl1b bind to different locations on the neck of the Myosin heavy 
chain than the RLCs, it is unlikely that they can compensate for a loss of mylpfa in the mylpfa-/- 
mutants. Therefore, higher RNA expression levels of mylpfa when compared to mylpfb could 
explain the critical role of mylpfa in muscle organization and function. 
 
 
Figure 4. mylpfa is the key Regulatory light chain gene in fast muscle 
(A) Protein alignments showing the two Regulatory Myosin light chains, Mylpfa and Mylpfb, and 
where they are truncated in mutants (green oval). Both mutants truncate in the first EF Hand 
domain (orange), which connects light chain proteins to Myosin heavy chains. (B) Muscle 
birefringence is bright in wild-type embryos (left most embryo) but dimmer in mylpfa mutants 
(asterisk). Mutants for mylpfb are indistinguishable from their wild-type siblings. (C) Graph of 
RNA-Seq data showing the number of fragments to the gene of interest (either mylpfa or 
mylpfb) per million mapped reads in wild-type at 21 hpf and 27 hpf. Individual points plotted 
come from different biological replicates. 
mylpfa mutants have impaired swimming and immotile pec fins 
Sarcomeres are the basic contractile unit of muscle cells. Knowing this, I screened the 
mutant lines for muscle weakness by assaying their swimming. As expected based on their 
normal muscle organization as assayed by birefringence, mylpfb-/- mutant swimming patterns 
were indistinguishable from their wild-type and heterozygous siblings. In mylpfa-/- mutants, 
which have a severe reduction in birefringence and thus severe loss of muscle organization, I 
observe a strong swimming defect when compared to their wild-type siblings or to the other 
Myosin light chain mutants. Compared to their wild-type siblings, mylpfa-/- mutants swim in an 
abnormal manner: they swim more slowly, are slower to respond to mechanical probing, and 
cannot hold themselves upright for very long. mylpfa-/- mutants also have immotile pectoral fins, 
which are pure fast muscle. These mylpfa-/-  specific swimming defects suggest that mylpfa is 
the critical Myosin light chain gene expressed in zebrafish fast muscle and is consistent with the 
finding that mylpfa expression is at a higher level than that of mylpfb.  
mylpfa mutants have reduced skeletal muscle contractile strength  
To quantitatively test how loss of mylpfa affects muscle strength, I worked with Brit 
Martin in the Janssen lab to measure the force of muscle contraction after electrostimulation. 
We measured the contractile strength of wild-type siblings, mylpfa+/-  heterozygotes, and mylpfa-
/- mutants (Figure 5A). A current of various frequencies passed over the body of the zebrafish 
induces muscle contraction. The resulting force the fish exerts when the current induces its 
body to contract is then recorded (Martin et al., 2015). At 72 hpf, the homozygous mylpfa-/- 
mutant embryos had a significant reduction in contractile strength compared to both their 
heterozygous and homozygous wild-type siblings at all frequencies. A reduction in muscle area 
cannot explain this reduction in contractile strength, as mylpfa-/- mutants have similar cross-
sectional muscle area than their wild-type siblings (Figure 5B). mylpfa+/-  heterozygotes are not 
significantly different than the wild-type siblings (Figure 5C). Additionally, the mylpfa-/- embryo 
myotome takes longer to reach peak contractile strength (Figure 5D) and is slower to relax 
(Figure 5E). This pattern of slower to reach peak force and to relax afterwards is characteristic 
of slow muscles, thus I hypothesize that the contractile strength of the mylpfa-/- mutants are 
mostly from the contraction of slow muscles. The mylpfa-/- mutant swimming defects we observe 
are significantly different from their wild-type and heterozygous siblings, potentially due to 






Figure 5. mylpfa is required for fast muscle contraction. 
(A) Graphs showing contractile force outputs of wild-type and mylpfa-/- mutants at 3 dpf when 
electro-stimulated by 20 Hz. (B) Confocal image of a cross section of 3 dpf wild-type and   
mylpfa-/- mutant embryos expressing transgenes to mark fast (green) and slow (red) muscles. 
Scalebar: 100 microns (C) Graph of the contractile force of wild-type (blue), mylpfa+/- 
heterozygotes (red), and mylpfa-/- mutants (green) over various stimulation frequencies. (D) Bar 
graph depicting the time for wild-type, mylpfa+/- heterozygotes, and mylpfa-/- mutants to reach 





Figure 6. mylpfa mutants lack in vitro Myosin heavy chain activity 
(A) Tracks of fluorescently labeled Actin filaments over time as they are moved by extracts from 
either wild-type of mylpfa-/- mutants. Filaments are tracked over 6 seconds using ImageJ and 
their location marked from time 0 (red) to 6 seconds (fuchsia/red). Scalebar: 10 microns (B) 
SDS gel of extracts enriched for Myosins from 3 dpf wild-type and mylpfa-/- mutant embryos. We 
quantified the area of the Myosin heavy chain band using Axiovision (unitless). The wild-type 
band has an area of 1410 and mylpfa-/- mutant band has an area of 1383. 
 
Supplemental Movie 1  
https://drive.google.com/open?id=18dDnzFlM7lt4J6Vg3P1ZLLmdw2n997Du 
Recording of fluorescently labeled Actin filaments on slide with 3 dpf wild-type Myosin extracts. 
 
Supplemental Movie 2 
https://drive.google.com/open?id=1xSr6ayDSoAuW5AEJbVFt-dUmu6QdjKMQ 
Recording of fluorescently labeled Actin filaments on slide with 3 dpf mylpfa-/- mutant Myosin 
extracts.  
 
mylpfa mutants lack in vitro Myosin heavy chain activity 
Since zebrafish muscle expresses mylpfa transcripts at a higher level than its duplicate, 
mylpfb, a mutation in the mylpfa gene is more severe than a mutation in mylpfb. If mylpfa and 
mylpfb have equivalent roles, then a mutation in mylpfa is more similar to a full loss of RLC. 
Previous research had shown that in vitro Myosin activity is reduced in the absence of the RLC 
(Lowey et al., 1993b). Based on this previous research on the loss of RLC on Myosin function 
as well as our in vivo results of muscle weakness, I tested the activity of Myosin extracted from 
mylpfa-/- mutants. In August 2017, I traveled to the University of Vermont to collaborate. 
Together, we extracted Myosins from 72 hpf wild-type and mylpfa-/- mutant embryos and 
measured their Actin-Myosin motility in vitro as described previously (Lin et al., 2018). The 
mylpfa-/- mutant extracts induced little to no Actin movement, a dramatic reduction compared to 
their wild-type siblings (Figure 6A, Supplemental Movies 1 and 2). Additionally, less total Actin 
is bound to the slide, suggesting that there are fewer Myosin heavy chains binding to the 
fluorescently labeled Actin. To ensure that a reduction in Myosin heavy chain protein doesn’t 
explain the reduction in Actin binding and Actin, I measured the relative Myosin heavy chain 
levels in wild-type versus mylpfa-/- mutants. We saw no difference in the band intensity for the 
band size corresponding to Myosin heavy chain protein when we ran Myosin-enriched on an 
SDS-Page gel (Figure 6B). Additionally, antibody labeling of Myosin heavy chain on sections of 
mylpfa-/- mutants does not appear significantly reduced when compared to their wild-type 
siblings (Figure 7D). Thus, I conclude that a loss of Mylpfa protein and not a reduction in 






Figure 7. mylpfa-/- mutants have sarcomeric organization defects but relatively normal 
overall muscle organization. 
(A) Confocal cross section of 26 hpf embryos labeled with antibodies for fast muscle (red), slow 
muscle (blue), and nuclei (green) markers show normal muscle type separation and myotome 
organization in mylpfa-/- mutants. (B) High magnification in confocal microscopy of 26 hpf 
embryos labeled for Actin (red), Myosin heavy chain (green) and myonuclei (blue) show poor 
co-localization between Myosin heavy chain and Actin in mylpfa-/- mutants. (C) Confocal images 
of fast (red) and slow (green) muscle fibers extracted from mylpfa-/- mutants. Scalebar: 100 
microns (D) Confocal images of sectioned 3 dpf embryos labeled with Actin (red) and Myosin 
heavy chain (green). mylpfa-/- mutants have both aggregates of Myosin heavy chain and 
patches of sarcomere organization. Scalebar: 5 microns 
 
Mylpfa mutants have severe defects in sarcomere development 
The Myosin heavy chains are present at wild-type levels in the mylpfa-/- mutants; 
however, the Myosin extracts bind and move fewer Actin filaments. I wanted to test in vivo 
whether the Myosin heavy chains are able to interact with Actin filaments. Additionally, I wanted 
to examine the muscle structure of the mylpfa-/- mutants since the reduction in birefringence 
suggests disorganization. At 26 hpf, overall muscle fiber organization appears normal in mylpfa-
/- mutant skeletal muscles (Figure 7A). Thus, slow and fast muscle fibers still develop and 
separate in mylpfa-/- mutants. To look more closely at the sarcomeric organization of the skeletal 
muscle, I observed the localization of the Myosin heavy chains in relation to the Actin using 
antibody labeling. In 26 hpf wild-type embryos, there is alternating labeling of Actin and Myosin, 
indicating that Myosin heavy chains and Actin are interacting with one another. In contrast, 
Myosin heavy chains and Actin do not display proper sarcomeric organization in 26 hpf mylpfa-/- 
mutants. Actin myofibrils are present in mylpfa-/- mutants, but they do not associate with Myosin 
heavy chain (Figure 7B). By 72 hpf, the fast muscle fibers themselves appear to have an 
abnormal morphology. It is difficult to observe exact morphology of individual fibers in the whole 
zebrafish embryo, so we isolated fast muscle fibers from wild-type and mylpfa-/- mutant embryos 
at 72 hpf. Isolated mutant fibers were more fragile than the wild-type fibers and often balled up 
or broke in transfer (Figure 7C). To examine both Actin and Myosin, I sectioned the 72 hpf 
embryos and labeled the sarcomeric structure. In mylpfa-/- mutants there are patches of 
sarcomeric organization, but most of the muscle fiber remains disorganized (Figure 7D). By 72 
hpf, much of the Myosin heavy chain appears to aggregate together instead of lining up with the 
actin filaments. Even within a single muscle fiber there may be small portions of sarcomere 
organization adjacent to globs of Myosin heavy chain aggregates. The aggregation of the 
Myosin heavy chain may explain why the Myosin extracts for the in vitro Actin activity assay was 
unable to bind to Actin at this developmental stage. Alternatively, the Myosin may never have 
been able to bind Actin in the absence of mylpfa-/-. The disorganization of sarcomeric structure 








Figure 8. Fast muscles in mylpfa-/- mutants degenerate between 3 and 6 dpf. 
Confocal section of embryos expressing transgenes marking fast muscle (green), slow muscle 
(blue), and nuclei (red). (A, B) Whereas wild-type muscle appears stable over time, (C, D) 
mylpfa-/- trunk muscles degenerate between 3 dpf and 6 dpf. (F-I) Projections of slow muscle 
marker smyhc1:GFP show muscles show that slow muscle is not overtly affected by loss of 
mylpfa. (K-Q) Other mylpfa expressing muscle groups such as the hypaxial and pectoral fin 
muscles (K-N) and the facial muscles (P, Q) also degenerate in mylpfa-/- mutants but not their 
wild-type siblings. (E, J, O, R) Images are of the region represented by the blue box on the 
illustrations of 3 dpf embryos. Scalebar: 100 microns 
 
 
Fast muscles in mylpfa-/- mutants degenerate between 72 hpf and 96 hpf 
 Despite the severe lack of sarcomeric organization at 72 hpf, fast muscle fibers in the 
mutants are only slightly more irregularly shaped than in wild-type embryos. To test the effect of 
time and increased mechanical activity on the mylpfa-/- mutant muscle, I followed the muscle 
fibers over time using transgenic markers of fast and slow muscles. Between 72 and 96 hpf, fast 
muscle fibers in the trunk rapidly degenerate into small islands of cells that have zero to two 
nuclei per cell (Figure 8A-E). The slow muscles, however, remain unaffected during this time 
(Figure 8F-J). Other groups of fast muscle fibers in the zebrafish such as the fin and hypaxial 
muscles (Figure 8K-O) and the facial muscles (Figure 8P-R) also exhibit this pattern of 
degeneration. In mylpfa-/- mutants, but not in their wild-type and heterozygous siblings, there is a 
significant increase in the number of breaks and small islands of cells (Figure 9, Supplemental 
Movie 3). Thus, in the absence of mylpfa, muscle fibers form, but lack the sarcomeric 
organization required for maintenance of muscle integrity. 
 
Figure 9. Fast muscles break along the length of myofibers in mylpfa-/- mutants, forming 
small rounded cell ‘islands’ 
Still images from timelapse of the hypaxial muscle of a mylpfa-/- mutant from 79 hpf to 91 hpf. 
The membrane of a single myofiber was pseudo colored green. Red arrow heads indicate 
points of pinching of the myofiber and yellow asterisks indicate breaks in the myofiber. 
Supplemental Movie 3 
https://drive.google.com/open?id=1goOyGVLW8NOt0PNQB7KzE2sGD6FYtHCU  
Timelapse of mylpfa-/- mutant from 79 hpf to 94 hpf with images taken every 7 minutes. 
Discussion 
 Despite similar amino acid sequences and spatial expression patterns, I identified mylpfa 
as the key Regulatory myosin light chain gene for muscle integrity and function. mylpfa-/- 
mutants exhibit severe sarcomeric organization defects beginning as early as 26 hpf. Wild-type 
embryos at 26 hpf have sarcomeric organization that resembles the nascent myofibrils 
described in the three-step model of myofibrillogenesis (Sanger et al., 2017). In contrast, in 
mylpfa-/- mutants, Actin filaments span the myofiber but are less organized than in wild-type 
siblings at the same developmental stage. If muscle Myosin does not integrate into the 
organized Actin filaments in what would be the second step of myofibrillogenesis, as the non-
muscle myosin degrades or leaves the pre-sarcomeric structure, the Actin may diffuse 
throughout the myofibril. Thus, a lack of functional Myosin heavy chains could lead to 
disorganization of Actin filaments. As more of the muscle Myosin should replace non-muscle 
Myosin, Actin structure in mylpfa-/- mutants disperses further, losing its previous organization. If 
Myosin heavy chain association with Actin filaments require mylpfa, this could explain the failure 
in the second step of myofibrillogenesis and the lack of sarcomeric organization in mylpfa-/- 
mutants. My data suggest that maintenance of Actin filamentous structure throughout the 
entirety of myofibril development requires the association of muscle Myosin heavy chains and 
Actin. 
In Drosophila, micro-contractions further form sarcomeric structure by aligning the other 
forming sarcomeres together during the maturation of the myofibril. In wild-type zebrafish, 
sarcomeric structure becomes more robust over time. In mylpfa-/- mutants, however, there are 
only patches of sarcomeric structure by 72 hpf, perhaps due to the other RLC mylpfb. To test 
whether mylpfb partially compensates for loss of mylpfa, I will examine mylpfa-/-; mylpfb-/- double 
mutants for the small patches of sarcomere organization. I hypothesize that in these double 
mutants, I will see no patches of sarcomeric organization even at 72 hpf. The patches in the 
single mylpfa-/- mutants may still be capable of localized contraction and align sarcomeres 
together. I could test whether it is levels of RLC that is important as opposed to a difference in 
mylpfa or mylpfb function by injecting embryos with mylpfb mRNA to overexpress mylpfb. If this 
is sufficient to rescue the mylpfa-/- mutants then the phenotype we observe is caused by 
insufficient levels of RLC and not a loss of mylpfa in particular. The amount of mylpfb in mylpfa-/- 
mutants is likely not enough to compensate for an entire myofibril, thus these sarcomeric 
structures remain localized. Over time, as these patches of sarcomeres mature, they strengthen 
and may be responsible for pulling in on the fiber, collapsing it. Thus, the patches of sarcomere 
structure may be responsible for the degeneration of mylpfa-/- mutant muscle. I propose a model 
in which a failure of proper sarcomere organization leads to muscle fiber collapse in areas 
lacking sarcomeres. Patches of sarcomeres that form further pull on the myofiber, breaking the 
muscle off into smaller mononucleated cell islands (Figure 10). The degenerated trunk fast 
muscles in zebrafish appear similar to the phenotype of the Mylpf-/- mutant newborn mouse 
(Wang et al., 2007). Perhaps the mouse Mylpf-/- mutant also has sarcomere organization and 
myofibrillogenesis that led to the muscle degeneration. To directly visualize how sarcomere 
structure corresponds to muscle ‘islands’ in our mylpfa-/- mutants, we could perform a time lapse 
using our muscle membrane marker (mylpfa: lyn-Cyan) and a sarcomere marker (LifeAct-
mCherry mRNA) in mylpfa-/- mutants during degeneration. My degeneration hypothesis supports 
that micro-contractions of the patches of sarcomere cause muscle degeneration. Thus, I 
hypothesize that myofibers will break along the myofiber adjacent to functional patches of 
sarcomere structure in mylpfa-/- mutants. Additionally, if the patches of sarcomere are 
destructive for the myofiber, if we were to inhibit muscle contraction via Myosin inhibitors, the 






Figure 10. Actin-Myosin interactions are required for sarcomere assembly and muscle 
integrity. 
(A) Model for wild-type sarcomere organization in myofibers. (B) Illustration of my model for the 
failure of sarcomere organization in mylpfa-/- mutants and how this leads to degeneration of 
myofibers. 
Another possible explanation could be that the small patches of sarcomere structure are 
not destructive in the mylpfa-/- mutants but are constructive in maintaining the shape of the 
smaller muscle islands. There is not enough sarcomere organization to maintain the shape of 
the entire myofibril; however, there is enough to maintain the integrity of the smaller islands. 
Thus, instead of the sarcomeres pulling the fiber apart, the fibers are collapsing in on the areas 
of the greatest absence of sarcomere structure. If these sarcomere patches in mylpfa-/- mutants 
are indeed due to the presence of mylpfb, in examining the mylpfa-/-; mylpfb-/- double mutants, 
we should see no sarcomere organization throughout the myofibril. If the patches of sarcomeres 
in mylpfa-/- mutants are constructive as opposed to destructive, in double mutants I should still 
see muscle degeneration, or perhaps degeneration that occurs sooner or with more breaks 
across the myofiber. Mylpf-/- mouse mutants do not have a duplicate of the RLC gene and still 
appear to be similar to the mylpfa-/- mutants, supporting the possibility of degeneration in  
mylpfa-/- mutants is due to the lack of the majority of sarcomere organization. 
Myosin heavy chains in mylpfa-/- mutants not only lack association with Actin, but also 
appear to aggregate by 72 hpf. In the absence of mylpfa, the Myosin heavy chains are likely 
unstable by themselves, leading to aggregates in the absence of Actin association. This 
aggregation of Myosin heavy chains could also explain why the in vitro assay of Myosin heavy 
chains activity was lower in mylpfa-/- mutants. The Myosins may not be able to ratchet Actin 
without mylpfa and may not be available to bind to the Actin because much of the Myosin has 
aggregated together. I will use Transmission Electron Microscopy to further visualize both the 
small patches of sarcomere structure and the Myosin heavy chain aggregates. Aggregates of 
sarcomeric proteins such as the Myosins have been associated with a group of muscular 
dystrophies known as myofibrillar myopathies (Sharma and Goebel, 2005). Thus, mylpfa-/- 
mutants may provide a model organism for studying such protein aggregate myopathies.  
 
Myosin heavy and light chains have been shown to be linked to several other disorders 
in human skeletal and cardiac muscles. Mutations in the slow muscle and cardiac myosin light 
chains MYL2 and MYL3 lead to skeletal and cardiac myopathies (Hwang and Sykes, 2015). 
Mutations in myosin heavy chains, another component of the sarcomere, have been linked to 
human diseases, including muscle degenerative diseases. Mutations in the slow myosin heavy 
chain MYH7 in humans that alter the protein’s confirmation are linked to Laing muscular 
myopathy, a form of muscular dystrophy (Meredith et al., 2004). Defects in sarcomeric proteins 
like Myosins may also help explain patient variation in Duchenne Muscular Dystrophy. Evidence 
of such a link has been shown in dystrophy patients with a null polymorphism in ACTN3, which 
normally encodes another sarcomeric protein, α-Actinin-3 (Hogarth et al., 2017). By 
understanding the roles of the Myosin light chains, such as Mylpfa, researchers can better 











Materials and Methods 
Fish maintenance, husbandry, and strains. 
Fish were raised and maintained under standard conditions and staged as described previously 
(Kimmel et al., 1995) Westerfield, 2007). I used the following transgenic lines to study the 
muscle structure: tg(smyhc1:EGFP)i104 referred to as smyhc1:GFP (Elworthy et al., 2008), 
tg(myog-Has.HIST1H2BJ:mRFP)fb121 referred to as myogenin:H2B-mRFP (Tang et al., 2016), 
tg(mylpfa:LY-CFP)fb122 referred to as mylpfa:lyn-cyan (Tang et al., 2016), and 
tg(mylpfa:mCherry)cz3327) referred to as mylpfa:mCherry (Ignatius et al., 2012). smyhc1:GFP 
was provided by Phil Ingham’s lab. mylpfa:H2b-mRFP, mylpfa:mCherry, and mylpfa:lyn-Cyan 
were provided by David Langenau’s lab. Mutant lines of the four Myosin light chain genes were 
constructed as described below.  
CRISPR mutagenesis 
CRISPR mutagenesis and mutant recovery was performed as described previously (Talbot and 
Amacher 2014). Jared Talbot designed and injected CRISPR/Cas9 into embryos to generate 
mutants in the four myosin light chain genes. We used guide oligo targeting sequence 
GGTGAAGTTGATTGGGCCGC to mutate mylpfa and screened for founders using primers 
TCTCTACAGGCCAGCTGAATG and ACCCTTCAACTTCTCTCCGAAC. To mutate mylpfb, we 
used guide RNA to target sequence GGAAAACAGTAAAGTTGATG and screened for potential 
founders using HRMA with primers GCAACAATGGGTCAGCTAAATG and 
GGTAAGTGAAGATTTGGACAACTC. myl1a was mutated using guide RNA to 
CGATTTCACCCAGGACCAGA and potential founders were identified using primers 
CCTGCAGCTCGATTTC and TGGAAGATTGTGTCAAAGG. We used guide RNA to target 
sequence GGGTCAGAACCCCACCAACA to mutate myl1b and identified founders using 
primers AGAGTTGGTGACAGCAAGGTTG and ATGGTCTTACCGTCAGCAGATG. Pooja 
Gangras identified founders and established the line of fish carrying null mutations in myl1b as 
well as conducted initial characterization of these mutants. Sarah Shepherd identified founders 
for myl1a and identified F1 fish carrying null mutations for mylpfb that I had identified the 
parental generation. I performed all other founder identification and allele sequencing. 
mylpfa^oz30 has a 20 bp deletion without further substitutions that frameshifts after amino acid 
76 of 169 and introduces 12 aberrant amino acids before termination. mylpfb^oz39 has a 5 bp 
deletion that frameshifts after amino acid 78 of 171 and introduces 9 aberrant amino acids 
before reaching a stop codon. myl1b allele is still pending. myl1b^oz14 is a 2 bp deletion without 
further substitutions leading to a frameshift after amino acid 46 of 151 and introduces 3 aberrant 
amino acids before reaching a stop codon. To genotype each of the Myosin light chain mutants, 
I use the same primers to identify founders as I used to identify founders of above mutants. Due 
to the large 20 bp deletion, mylpfa PCR product could be run on a 3% agarose gel to identify 
mutants. mylpfb PCR products must first be digested by Bccl and then run on a 2% gel. The 
mutated allele for myl1a has yet to be confirmed by homozygous mutant analysis so as of now 
they are genotyped by HRMA. Finally, myl1b is genotyped by digesting PCR products with BslI 
with an extra cut site introduced in the myl1b mutants. 
Tissue labeling 
Antibodies and stains used for tissue labeling are as follows: Rbfox1l (recognized with Rabbi-
405, conc. 1:500), A4.1025 (recognized with IgG2a-633, conc. 1:100), A4.1025 (recognized with 
IgG2a-488, conc. 1:100), F310 (recognized with IgG1-546, conc. 1:1000), and Phalloidin-546 
(conc. 1:20 at 26 hpf, 1:50 at 3 dpf sections). Embryos were fixed in 4% PFA for two hours at 
room temperature or overnight at 4 degrees. Embryos were then washed out of fixative into 1X 
Phosphate Buffered Saline Tween-20 (PBST). If embryos were 3 dpf, they were briefly treated 
with Proteinase K to make them more permeable to the antibodies. Embryos were then placed 
in K block (1XPBS, 0.5% TritonX-100, 4% NGS 2% NSS 1% DMSO) for at least two hours at 
room temperature. Primary antibodies were prepared in K block and were added to embryos, 
rocking at room temperature overnight. Embryos were then washed in PBST-B-N (1X PBS, 
0.1% Tween-20, 2% BSA, and 5% NGS) once then in PBST-B (1X PBS, 0.1% Tween-20, 2% 
BSA) three times over an hour. Secondary antibodies are also prepared in K block and allowed 
to preabsorb for at least 20 minutes before being added to the fixed embryos. Embryos then 
rock at room temperature for four hours or overnight at 4 degrees, after which they are washed 
out of secondary antibodies and into PBST. 
Tissue Labeling of sections 
Zebrafish embryos were raised to 3 dpf and then sectioned on the Cryostat by Kimberly 
Hromowyk. Eight sections were placed on each slide and rinsed for 30 minutes in 1X PBS. 
Sections on the slide were then outlined using a DAKO pen. Tissue was then permeabilized 
using 0.5% Triton in 1X PBS for 10 minutes. Sections were washed in 1X PBS for 10 minutes 
before being washed in block (0.03 g/mL BSA in 1X PBS) for 20 minutes. Primary antibodies 
were made in block and added to the sections overnight at 4 degrees. Slides were then washed 
in 1X PBS 4 times over an hour. Sections were treated with 0.1% Triton/1X PBS for 10 minutes 
before secondary antibodies were added and left at 4 degrees overnight. Finally, slides were 
washed in 1X PBS for 2 hours and coverslips were added. Slides were then imaged an inverted 
Nikon TiE microscope with an Andor Revolution WD spinning disk confocal system. 
Birefringence 
Zebrafish embryos were characterized for the optical property of birefringence. 3 dpf embryos 
were anesthetized using tricaine and 10 embryos were transferred to a 1 mL glass bottom dish 
at a time. Two polarizing filters were placed on the light microscope and rotated 90 degrees to 
one another. Because muscle is birefringent, it rotates light between these filters making the 
muscle appear to light up Embryos were then sorted based on their birefringent characteristics 
and transferred to new plates.  
mRNA in situ hybridization 
Fluorescent mRNA in situ hybridization was performed as described (Talbot et al., 2010) and 
non-fluorescent RNA in situ hybridization used established protocols (Jowett, 1999), with slight 
modifications as follows. Embryos were treated with 1µg/ml Proteinase K for 5 minutes (24 hpf 
embryos) or for 45 minutes (52.5 hpf embryos). For in situs of time points after 1 dpf, embryos 
were treated with 0.003% N-Phenylthiourea (PTU) beginning at 24 hpf to prevent pigment 
formation. The mylpfa and smyhc1 probes have been previously described (von Hofsten et al., 
2008; Xu et al., 2000). We also confirmed the mylpfa expression pattern using an independent 
probe that I generated. I also generated the probe to mylpfb that covers 408 bp of the coding 
region and the 3’ UTR from cDNA using the primers AGTGGCCCCATCAACTTTACTG and 
AGCCCAAATGCCAACAAACC. I also generated the probe to myl1a that covers 723 bp of the 
coding and 3’ UTR sequence using cDNA from the primers 
TCCACTCCCTGTGTCGTGTTCCTTC and GTGTCCCTTTCATCCGTTTCTGAGTTGG. Jared 
Talbot generated the myl1b probe that covers 403 bp of the 3’ UTR from cDNA using the 
primers CGTCTAGGGAGTGGTGAAGAAG and ATGACTGTGTGAAAATTGGGATGG. 
Embryos were mounted for imaging as described in (Morrow et al., 2017).  
RNA-seq 
RNA-seq was conducted by Pooja Gangras. For RNA-seq, mRNA was harvested from 21 and 
27 hpf wild-type embryos, then ligated to a homemade linker library and sequenced on an 
Illumina HighSeq2500. RNA-seq conclusions were confirmed using publicly available data from 
The European Bioinformatics Institute (EMBL-EBI) Expression Atlas 
(https://www.ebi.ac.uk/gxa/experiments/E-ERAD-475/Results) 
In vitro Myosin functional assay 
In vitro motility assay was performed by Amy Li from David Warshaw’s lab using embryos that I 
de-yolked and then permeabilized using Trypsin. I transferred 3 dpf embryos sorted mutant or 
wild-type by swimming behavior and birefringence to a plate of 2 mL of protease solution (2.5 
mg/mL Trypsin, 0.2% 0.5 EDTA, 10% 10X phosphate-buffered saline (PBS), sterile H20 to 
desired volume) with 0.1% tricaine solution for 7.5 minutes. 500 microliters of stop solution (25% 
fetal calf serum/fetal bovine serum, 0.5% 1M calcium chloride, 10% 10X PBS, 64.5% sterile 
water) to the embryos. After 1 minute, embryos were transferred to a new plate of Ringer’s 
solution (0.29% 1 M potassium chloride, 2.32% 5 M sodium chloride, 0.5% 1 M Hepes pH 7.2, 
96.89% sterile water). Embryos were then placed in a flow cell and washed with buffer and salt 
solutions to extract Myosins as described in (Scheid et al., 2017). The Myosins stick to the 
surface of the flow cell and fluorescently labeled Actin is washed through the flow cell and is 
bound by the Myosin. The fluorescently labeled Actin filaments are then imaged over 6 seconds. 
Muscle motility assay 
Functional muscle motility assay was performed by Brit Martin as described in (Martin et al., 
2015). Embryos were raised to 3 dpf and mutants were sorted by their swimming defects. 
Anesthetized embryo tails were hooked to a force transducer and their head affixed in place. 
Embryos were stimulated for 250 ms at 20, 50, 80, 120, 150, and 180 Hz. Embryos were left 
unstimulated for 2 minutes between stimulations. I then genotyped these embryos to confirm 
mutant genotype and sort between wild-type and heterozygous embryos.  
Time lapse imaging 
mylpfa-/- mutants carrying the transgenic lines smyhc1:GFP, myogenin:H2B-mRFP, and 
mylpfa:lyn-cyan were raised to 3 dpf and sorted positive for expressing all three transgenes and 
mutant swimming phenotype. Embryos were mounted in system water with 0.2% agarose 
(GeneMate E-3120-500) that was heated and then cooled to 42 degrees before adding tricaine 
to a concentration of 0.02%. Embryos were then imaged using an inverted Nikon TiE 
microscope with an Andor Revolution WD spinning disk confocal system and analyzed using 
Metamorph software. Imaged embryos were then raised to 6 dpf in normal system water to 
check for health. Finally, genotype was confirmed using PCR. 
Muscle fiber isolation 
Similar to the first steps of the in vitro Myosin functional assay, embryos were raised to 3 dpf 
and sorted by the mutant swimming phenotype and by the reduction in birefringent character. 
The embryos were then placed in Ringer’s solution with 0.02% tricaine solution. Insect pokers 
were used to remove the yolks of the embryos. Embryos were transferred to a new plate of 
ringers and placed on a horizontal shaker for 5 minutes. Embryos were then transferred to a 
plate of 2 mL of protease solution with 0.1% tricaine solution for 7.5 minutes. 500 microliters of 
stop solution to the embryos. After one minute, embryos were transferred to a new plate of 
Ringer’s solution. Embryos were rotated ventral side up, held in place with an insect poker by 
the head, and sliced from neck to abdomen using another insect poker to loosen the myofibers. 
Embryo is then turned over and shaken to pour out the fibers. Isolated fibers can be transferred 
using a P20 pipette.  
Crude Myosin extraction and SDS-PAGE gel 
For crude Myosin extraction, 20 embryos sorted mylpfa-/- mutant or wild-type by their swimming 
defects and birefringence were deyolked and lysed in liquid nitrogen. Myosins were enriched by 
following a modified protocol for extracting myosins from a chicken muscle (Racusen and 
Thompson, 1997). Myosins were extracted in a high salt buffer and further enriched by dilution 
in water to allow for polymerization of the heavy chains, leading to insolubility. To minimize 
protein degradation, all extractions were performed on ice. Myosin pellets were suspended in 50 
microliters and 10 microliters were run on a Bolt 4-12% Bis-Tris Plus Acrylamide gel (BG04125) 








Many individuals were instrumental to putting together all of this data and helping me 
throughout my undergraduate project. Other than myself, Jared Talbot, Pooja Gangras, and 
Sarah Shepherd were integral in the construction of the Myosin light chain mutant zebrafish 
lines. I’d also like to thank Kimberly Hromowyk, Brit Martin, Amy Li, and David Warshaw for their 
expertise, time, and assistance in characterizing aspects of the mylpfa-/- mutant phenotype.   
I’d like to thank the many individuals that helped me through my undergraduate research 
career. I’d like to thank Sharon Amacher for accepting me into her lab back in my freshman year 
before I had even taken a genetics course. She has been a caring and knowledgeable mentor 
throughout my time in the lab and I will always look back on my time fondly. I am so grateful for 
my great mentor, Jared Talbot, who has taught me everything from how to pipette to how to 
design and think about the next steps to a project. He also provided his artistic skills in 
illustrating the cartoons shown in figures 1, 2 and 7. The other members of the Amacher lab 
have always been quick to help if I needed it, supportive in lab meetings, and welcoming to me. 
I feel very fortunate to have found such a genuinely kind, supportive, and intelligent lab to work 
in. My work at Sharon Amacher’s lab has helped me to become a better student, a better 
scientist, and has been instrumental to my undergraduate career. I am so glad to be able to 
share all the work I’ve done the past three and a half years in the lab. 
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